✦ LIBER ✦

Controlled release of sirolimus from a multilayered PLGA stent matrix

✍ Scribed by Xintong Wang; Subbu S. Venkatraman; Freddy Y.C. Boey; Joachim S.C. Loo; Lay Poh Tan

Book ID: 108069731
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 343 KB
Volume: 27
Category: Article
ISSN: 0142-9612
DOI: 10.1016/j.biomaterials.2006.07.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Controlled loading and release of a mode

Controlled loading and release of a model drug from polypeptide multilayer nanofilms

✍ Yang Zhong; Catherine F. Whittington; Ling Zhang; Donald T. Haynie 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 886 KB

Physical characterization of controlled

Physical characterization of controlled release of paclitaxel from the TAXUS? Express2? drug-eluting stent

✍ Ranade, Shrirang V. ;Miller, Kathleen M. ;Richard, Robert E. ;Chan, A. Ken ;Alle 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

## Abstract The polymer carrier technology in the TAXUS™ drug‐eluting stent consists of a thermoplastic elastomer poly(styrene‐__b__‐isobutylene‐__b__‐styrene) (SIBS) with microphase‐separated morphology resulting in optimal properties for a drug‐delivery stent coating. Comprehensive physical chara

Controlled release of carbamazepine from

Controlled release of carbamazepine from carboxymethyl chitosan-grafted- 2-hydroxyethylmethacrylate matrix tablets

✍ Nirmal K. Patel; Jigar Joshi; Deepak Mishra; Vishnu A. Patel; Vijay Kumar Sinha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 581 KB

Control of cilostazol release kinetics a

Control of cilostazol release kinetics and direction from a stent using a reservoir-based design

✍ Theodore Parker; Vipul Davé; Robert Falotico; Jonathon Zhao; Thai Nguyen; Sylvia 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 893 KB

## Abstract Sustained release formulations of a potent antithrombotic drug, cilostazol, in poly‐(lactic acid‐__co__‐glycolic acid) (PLGA) matrices were created for luminal release from a novel drug‐eluting stent utilizing reservoirs (RES TECHNOLOGY™). The crystallinity of cilostazol and the morphol

Controlled release of IGF-I from a biode

Controlled release of IGF-I from a biodegradable matrix improves functional recovery of skeletal muscle from ischemia/reperfusion

✍ David W. Hammers; Apurva Sarathy; Chantal B. Pham; Charles T. Drinnan; Roger P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB

Controlled antibody release from a matri

Controlled antibody release from a matrix of poly(ethylene-co-vinyl acetate) fractionated with a supercritical fluid

✍ W. Mark Saltzman; Norman F. Sheppard Jr.; Mark A. Mchugh; Richard B. Dause; J. A 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 581 KB

## SYNOPSIS A new method is presented for controlling the rate of antibody ( Ab) release from a n inert matrix composed of poly (ethylene-co-vinyl acetate) ( EVAc) , a biocompatible polymer that is frequently used to achieve controlled release. Using supercritical propane, a parent EVAc sample ( M